# Pathologic and Immunologic Response After Ablative Radiation in Lung Cancer

> **NCT03603002** · NA · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 6 (actual)

## Conditions studied

- Non-small Cell Lung Cancer Stage I

## Interventions

- **DIAGNOSTIC_TEST:** Post-SABR Biopsy

## Key facts

- **NCT ID:** NCT03603002
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-16
- **Primary completion:** 2021-09-01
- **Final completion:** 2025-06-27
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03603002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03603002, "Pathologic and Immunologic Response After Ablative Radiation in Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03603002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*